Three dosimetry models of lipoma arborescens treated by 90Y synovectomy

被引:4
|
作者
O'Doherty, Jim [1 ,2 ]
Clauss, Ralf [3 ]
Scuffham, James [4 ]
Khan, Aman [5 ]
Petitguillaume, Alice [6 ]
Desbree, Aurelie [6 ]
机构
[1] Royal Surrey Cty Hosp, Dept Med Phys Nucl Med, Guildford GU2 7XX, Surrey, England
[2] Kings Coll London, St Thomas Hosp, Div Imaging Sci, PET Imaging Ctr, London SE1 7EH, England
[3] Royal Surrey Cty Hosp, Dept Nucl Med, Guildford GU2 7XX, Surrey, England
[4] Royal Surrey Cty Hosp, Dept Med Phys Nucl Med, Guildford GU2 7XX, Surrey, England
[5] Royal Surrey Cty Hosp, Dept Rheumatol, Guildford GU2 7XX, Surrey, England
[6] Inst Radioprotect & Surete Nucl, Serv Dosimetrie Interne, F-92260 Fontenay Aux Roses, France
基金
英国惠康基金; 英国工程与自然科学研究理事会;
关键词
dosimetry; lipoma arborescens; OLINDA; nuclear therapy; INTERNAL DOSE ASSESSMENT; S VALUES; THERAPY; LIVER; METASTASES; GUIDELINE; SOFTWARE;
D O I
10.1118/1.4870382
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: Lipoma arborescens (LA) is a benign intra-articular lipomatous proliferation of the synovial membrane. This extremely rare condition has previously been treated by intra-articular Y-90 radiosynoviorthesis but dosimetry literature on this form of radionuclide therapy is nonexistent. The authors detail methodology for successful treatment of LA and provide for the first time estimates of radiation dosimetry. The authors also analyze the biodistribution of the radiopharmaceutical over the course of the patient's treatment through sequential imaging. Methods: A patient with bilateral LA underwent intracavity injection of Y-90 citrate colloid to the right and left knee joint spaces (181 and 198 MBq, respectively). SPECT/CT datasets were acquired over 9 days to quantify the biodistribution and kinetics of the radiopharmaceutical. Radiation dosimetry was performed using the MIRD schema (through OLINDA software), a custom voxel-based method, and a direct Monte Carlo calculation (OEDIPE). Results: Follow-up MRI showed marked reduction in LA size in both knees. Mean absorbed doses to the LA were 21.2 +/- 0.8 and 42.9 +/- 2.3 Gy using OLINDA, 8.1 +/- 0.3 and 16.7 +/- 0.5 Gy using voxel based methodology, and 8.2 +/- 0.3 and 15.7 +/- 0.5 Gy for OEDIPE in the right and left LA, respectively. Distribution of the radiopharmaceutical within the joint space alters over the imaging period, with less than 1% of the remaining activity having moved posteriorly in the knee cavity. No uptake was detected outside of the joint space after assessment with whole-body scintigraphy. Conclusions: An activity of approximately 185 MBq successfully relieved clinical symptoms of LA. There was good correlation between direct Monte Carlo and voxel based techniques, but OLINDA was shown to overestimate the absorbed dose to the tumor. Accurate dosimetry may help select an activity more tailored to the specific size and location of the LA. (C) 2014 American Association of Physicists in Medicine.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Evaluation of 99mTc-MAA SPECT/CT-based dosimetry with 90Y PET/MR-based dosimetry in 90Y microsphere treatment
    Namazova, A.
    Yeyin, N.
    Besli, L. Uslu
    Sonmezoglu, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S635 - S636
  • [22] Patient and personnel dosimetry in endovascular radiotherapy with 90Sr/90Y sources
    Kalef-Ezra, J
    Bozios, G
    Tsekeris, P
    Michalis, L
    RADIATION PROTECTION DOSIMETRY, 2005, 114 (04) : 514 - 523
  • [23] Advancing Patient-Specific Dosimetry in 90Y Radioembolisation (SIRT): Added Benefit of Monte Carlo Simulation of 90Y PET
    Anderl, J.
    Beyer, T.
    Haug, A.
    Hoffmann, M.
    Hirtl, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S333 - S333
  • [24] Dosimetry for 90Y DOTATOC therapies, calculation of absorbed dose to kidney
    Krstic, D.
    Jeremic, M.
    Nikezic, D.
    Matovic, M.
    Krstic, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S529 - S529
  • [25] Evaluating Safety and Dosimetry of SBRT following 90Y for Hepatocellular Carcinoma
    Campbell, S. R.
    Juloori, A.
    LaHurd, D.
    Yu, N.
    Haddadin, I.
    Levitin, A.
    McLennan, G.
    Menon, K. V. N.
    Aucejo, F.
    Woody, N. M.
    Stephans, K. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E51 - E51
  • [26] Conjuctival carcinoma treated by brachytherapy with 90SR/90Y
    Jancar, B.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S252 - S253
  • [27] Dosimetry in Radiosynoviorthesis: 90Y VS. 153Sm
    Torres Berdeguez, Mirta Barbara
    Thomas, Sylvia
    Medeiros, Susie
    de Sa, Lidia Vasconcellos
    Milian, Felix Mas
    da Silva, Ademir Xavier
    HEALTH PHYSICS, 2018, 114 (01): : 1 - 6
  • [28] Colloidal 90Y used for radiation synovectomy decreases the viability of chondrocytes in human cadaveric samples
    Brecelj, Janez
    Gmeiner-Stopar, Tanja
    Jevsek, Marko
    Bole, Velimir
    Drobnic, Matej
    NUCLEAR MEDICINE COMMUNICATIONS, 2007, 28 (09) : 704 - 710
  • [29] The results of 394 consecutive cases of knee joint radiation synovectomy (radiosynoviorthesis) using 90Y
    Miszczyk, Marcin
    Jochymek, Bozena
    Miszczyk, Leszek
    Matysiakiewicz, Jacek
    Spindel, Jerzy
    Jablonska, Iwona
    Mrozek, Tomasz
    Chrobok, Adam
    Tomasik, Patryk
    Zakrzewski, Tomasz
    Tukiendorf, Andrzej
    ANNALS OF NUCLEAR MEDICINE, 2020, 34 (02) : 94 - 101
  • [30] The results of 394 consecutive cases of knee joint radiation synovectomy (radiosynoviorthesis) using 90Y
    Marcin Miszczyk
    Bożena Jochymek
    Leszek Miszczyk
    Jacek Matysiakiewicz
    Jerzy Spindel
    Iwona Jabłońska
    Tomasz Mrożek
    Adam Chrobok
    Patryk Tomasik
    Tomasz Zakrzewski
    Andrzej Tukiendorf
    Annals of Nuclear Medicine, 2020, 34 : 94 - 101